ROHRBERG, Kristoffer S. et al. Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers. Acta Oncologica, [S. l.], v. 51, n. 2, p. 234–242, 2012. DOI: 10.3109/0284186X.2011.619568. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/30634. Acesso em: 21 may. 2026.